For over two decades, CHRF has been conducting pneumococcal surveillance in Bangladesh, contributing critical evidence on disease trends and vaccine impact.

On 21 May at ISPPD-14, Dr. Senjuti Saha presented findings from this long-term surveillance work, highlighting how large-scale rural and urban surveillance, combined with genomics and antimicrobial resistance (AMR) data, is helping track the impact of pneumococcal vaccine (PCV) since its introduction in Bangladesh in 2015.

Dr. Saha also moderated an engaging and interactive Meet-the-Expert session on pneumococcal vaccine coverage and equity in a changing world.

At CHRF, we are proud to be part of a global effort that brings together scientists and public health experts to exchange knowledge, advance research, and support evidence-based public health decisions worldwide.